NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2021 – Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Clinical Trials Application Ready

2 years ago

SHELTON, CT / ACCESSWIRE / February 15, 2022 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in…

Panacea Life Sciences, Inc. Launches a Powerful 3300mg Cannabidiol Oral Solution Tincture

2 years ago

GOLDEN, CO / ACCESSWIRE / February 15, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), ("Panacea" or the "Company"), a Colorado,…

Zomedica Appoints Adrian Lock to Lead Sales Organization

2 years ago

ANN ARBOR, MI / ACCESSWIRE / February 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

XIL Health Develops Interactive Vaccine Dashboard with COVID Tracker for Pharmacies Nationwide

2 years ago

This unique product gives pharmacies access to data on COVID vaccines, flu shots and more, including distributions and reimbursements from…

AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch

2 years ago

AXIM is driven to positively transform the state of Dry Eye Disease (DED) testing and diagnosisThe company will deploy industry…

Digipath Announces Financial Results for Q1, 2022

2 years ago

Quarter Saw Large Increases Quarter Over Same Quarter Gross Profit and Revenue Gains LAS VEGAS, NV, Feb. 15, 2022 (GLOBE…

Athenex Announces Completion of Sale of Dunkirk Manufacturing Facility

2 years ago

BUFFALO, N.Y., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,…

Renibus Therapeutics Announces Appointment of Frank Stonebanks as CEO and $35 Million Series A Funding

2 years ago

Frank Stonebanks Headshot Frank Stonebanks, CEO, Renibus Therapeutics Founder, CEO and healthcare venture capitalist, Stonebanks brings 25 years of experience…

Novan to Report Full Year 2021 Financial Results on February 22, 2022

2 years ago

DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it…

Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market

2 years ago

MONTREAL, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the "Company" or "Sunshine Biopharma"), a…